Congress - Washington, District of Columbia, U.S.A.
The expectations of what constitutes an effective compliance program continue to evolve each year. Repeated high-dollar settlements and high-profile CIAs exemplify the need for innovative compliance solutions. The demand for well-trained, thoughtful and decisive compliance professionals is at an all-time high.
CBI’s Compliance Series addresses all aspects of a corporate compliance program to bring together Chief Compliance Officers and their teams to share best practices and evolve compliance efforts across the industry. This Series is headlined by this flagship meeting, CBI’s Annual Pharmaceutical Compliance Congress.
Tuesday, January 24, 2012 to Wednesday, January 25, 2012
Washington, District of Columbia, U.S.A.
Contact: (cbireg@cbinet.com)
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
